TED360 Forum

900 Newport Center Dr,Newport Beach CA 92660

26 March, 2022

Description

Earn CME with ABO CC Part II FacultyRaymond S. Douglas, MD, PhD (Course Chair) Kimberly Cockerham, MD, FACS Suzanne K. Freitag, MD Andrea Lora Kossler, MD, FACS Louise A. Mawn, MD, FACS Christian Nasr, MD Terry J. Smith, MD Prem S. Subramanian, MD, PhD Shoaib Ugradar, MD, FAAO, MRCP, MRCS Sara Tullis Wester, MD, FACS OverviewThyroid eye disease (TED) is a multifactorial, autoimmune disorder with a wide spectrum of signs and symptoms. It is frequently misdiagnosed, due to both the heterogeneous clinical presentation and a failure to understand the relationship between TED and hyperthyroidism. Misdiagnosis can place patients at increased risk for complications; however, a differential diagnosis can be achieved with the assistance of imaging, and early diagnosis and treatment may limit disfigurement and reduce vision loss. Ophthalmologists, oculoplastic surgeons, ophthalmic plastic and reconstructive surgeons, neuro-ophthalmologists, and endocrinologists should be knowledgeable about the conventional and new therapies available for the treatment of patients with TED and how to apply this information into practice. While new information on TED continues to be published and presented, there is a need for an educational forum that addresses the gamut of its management. The full-day, live, hybrid TED360 Forum aims to provide health care professionals with guidance on the appropriate use of therapies and strategies for delivering individualized care to patients with TED. In this case-based program, expert faculty discuss the available treatment options, and they will review the ongoing research in TED, surgical trends, and targeted insulin-like growth factor 1 receptor (IGF-1R) therapy. The program will also provide a venue in which treaters can openly discuss and address, in a collegial fashion, the latest advances in terms of knowledge about TED pathogenesis, diagnosis, and management options. The TED360 Forum will incorporate didactic presentations, collegial conversations, interactive case challenges, as well as live question-and-answer sessions. Learning ObjectivesUpon successful completion of this activity, participants should be better able to: Review the etiology, pathogenesis, and risk factors for TED to better understand why early diagnosis can improve outcomes in patients.Examine current guidelines and best practices that can improve the diagnosis of TED so that early treatment can be initiated.Assess the safety and efficacy of current medical treatments that can improve the management of patients with TED.Evaluate the benefit/risk profile of IGF-1R therapy and how it may be incorporated into practice, safely and effectively.Describe conventional and novel surgical and aesthetic procedures that have improved overall outcomes in patients with TED.Explore current research about the disease state and investigational therapies that may potentially improve the treatment of TED.Summarize new research that examines how concepts and clinical trial designs for TED studies and its management can become a reality.Examine case presentations, clinical findings, and management solutions that may improve overall outcomes for patients with TED.Target AudienceThe intended audience for this activity is oculoplastic surgeons, ophthalmic plastic and reconstructive surgeons, neuro-ophthalmologists, endocrinologists, ophthalmologists and other health care professionals involved in the management of patients with TED. This continuing medical education activity is provided by Vindico Medical Education. This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. To view the complete agenda and CME information, please visit TED360Forum.com. Questions? Contact Us: [email protected] Privacy Policy Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086